Skip to main content
PMC home page
Journal of Bacteriology logoLink to Journal of Bacteriology
. 1969 Sep;99(3):867–875. doi: 10.1128/jb.99.3.867-875.1969

Morphological Changes of Mycobacterium lepraemurium Grown in Cultures of Mouse Peritoneal Macrophages1

Y T Chang a, R N Andersen b
PMCID: PMC250105  PMID: 4905541

Abstract

Studies were made on morphological changes of Mycobacterium lepraemurium grown in cultures of mouse peritoneal macrophages. Two types of nonsolid or irregularly stained M. lepraemurium were observed. One type occurred in the growth phase of the organisms during the stage of preparation for bacillary multiplication. The nonsolid bacilli appeared as elongated organisms having pointed ends, isolated acid-fast dots, or faintly stained areas at the ends of the bacilli. It is possible that this irregularity in staining is due to a very gradual, versus an instantaneous, acquisition of acid-fast material during bacillary multiplication and maturation. Solid forms were again observed upon maturation. Nonsolid bacilli were also observed in macrophage cultures infected with autoclave-killed M. lepraemurium. Under these conditions there was an emergence of organisms which showed irregularly stained areas and various forms of deformity unaccompanied by elongation or multiplication. These irregularities were most probably due to the destructive process of digestion of bacillary protoplasm. The present study does not support the current hypothesis that all nonsolid acid-fast organisms are nonviable.

Full text

PDF
867

Images in this article

870Image
on p.870
873Image
on p.873

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkinson A. J., Jr, Sheagren J. N., Rubio J. B., Knight V. Evaluation of B.663 in human leprosy. Int J Lepr Other Mycobact Dis. 1967 Apr-Jun;35(2):119–127. [PubMed] [Google Scholar]
  2. BROWNE S. G., HOGENZEIL L. M. Apparent resistance of M. leprae to "B 663". Lepr Rev. 1962 Jul;33:185–189. [PubMed] [Google Scholar]
  3. BROWNE S. G., HOGERZEIL L. M. "B 663" in the treatment of leprosy. Preliminary report of a pilot trial. Lepr Rev. 1962 Jan;33:6–10. [PubMed] [Google Scholar]
  4. Browne S. G. The transient reappearance of morphologically normal M. leprae in patients under treatment. Lepr Rev. 1967 Apr;38(2):83–86. doi: 10.5935/0305-7518.19670016. [DOI] [PubMed] [Google Scholar]
  5. CHANG Y. T. LONG-TERM CULTIVATION OF MOUSE PERITONEAL MACROPHAGES. J Natl Cancer Inst. 1964 Jan;32:19–35. [PubMed] [Google Scholar]
  6. Chang Y. T. Further studies on B.663 in murine leprosy. Absence of resistance of M. lepraemurium to B.663 and delay in development of resistance to isoniazid. Int J Lepr Other Mycobact Dis. 1966 Jan-Mar;34(1):1–6. [PubMed] [Google Scholar]
  7. Chang Y. T. Story behind the clinical trial of B.663 in leprosy. Int J Lepr Other Mycobact Dis. 1967 Jan-Mar;35(1):78–80. [PubMed] [Google Scholar]
  8. Change Y. T., Andersen R. N., Vaituzis Z. Growth of Mycobacterium lepraemurium in cultures of mouse peritoneal macrophages. J Bacteriol. 1967 Mar;93(3):1119–1131. doi: 10.1128/jb.93.3.1119-1131.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. HANKS J. H. The infectiousness of murine leprosy bacilli after exposure to different conditions in vitro. Int J Lepr. 1952 Jan-Mar;20(1):67–81. [PubMed] [Google Scholar]
  10. Pettit J. H., Rees R. J., Ridley D. S. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy. Int J Lepr Other Mycobact Dis. 1967 Jan-Mar;35(1):25–33. [PubMed] [Google Scholar]
  11. REES R. J., VALENTINE R. C. A modified Ziehl-Neelsen staining method for identifying dead Mycobacterium leprae murium. Int J Lepr. 1962 Oct-Dec;30:414–417. [PubMed] [Google Scholar]
  12. REES R. J., VALENTINE R. C. The appearance of dead leprosy bacilli by light and electron microscopy. Int J Lepr. 1962 Jan-Mar;30:1–9. [PubMed] [Google Scholar]
  13. REES R. J., VALENTINE R. C., WONG P. C. Application of quantitative electron microscopy to the study of Mycobacterium lepraemurium and M. leprae. J Gen Microbiol. 1960 Apr;22:443–457. doi: 10.1099/00221287-22-2-443. [DOI] [PubMed] [Google Scholar]
  14. Rees R. J. Recent bacteriologic, immunologic and pathologic studies on experimental human leprosy in the mouse foot pad. Int J Lepr. 1965 Jul-Sep;33(3 Suppl):646–657. [PubMed] [Google Scholar]
  15. Ridley D. S., Ridley M. J. The possible significance of the club-forms of Mycobacterium leprae. Int J Lepr Other Mycobact Dis. 1968 Jul-Sep;36(3):339–340. [PubMed] [Google Scholar]
  16. SHEPARD C. C., MCRAE D. H. MYCOBACTERIUM LEPRAE IN MICE: MINIMAL INFECTIOUS DOSE, RELATIONSHIP BETWEEN STAINING QUALITY AND INFECTIVITY, AND EFFECT OF CORTISONE. J Bacteriol. 1965 Feb;89:365–372. doi: 10.1128/jb.89.2.365-372.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. WATERS M. F., REES R. J. Changes in the morphology of Mycobacterium leprae in patients under treatment. Int J Lepr. 1962 Jul-Sep;30:266–277. [PubMed] [Google Scholar]
  18. Warren A. G. A preliminary report on the use of B663 in the treatment of Chinese leprosy patients with chronic reaction. Lepr Rev. 1968 Apr;39(2):61–66. doi: 10.5935/0305-7518.19680011. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES